Results 171 to 180 of about 42,899 (196)

Radiogenomics of Stereotactic Radiotherapy: Genetic Mechanisms Underlying Radiosensitivity, Resistance, and Immune Response. [PDF]

Genes (Basel)
Vučinić D, Bukovica Petrc AM, Antončić I, Kolak Radojčić M, Lekić M, Couñago F.   +5 more
europepmc   +1 more source

Safety and Synergy of Capmatinib Plus Stereotactic Radiotherapy in MET Exon 14-Mutated Non-Small Cell Lung Cancer: A Case Report. [PDF]

Cureus
Bensalah O, Naciri M, Boudraa MA, Aouzah F, Kouhen F.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame

International Journal of Radiation Oncology Biology Physics, 2005
Yukinori Matsuo, , Shinsuke Yano
exaly  

Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?

Nature Reviews Clinical Oncology, 2016
J W Hodge, Sunil Krishnan
exaly  

Stereotactic Body Radiotherapy for Treatment of Adrenal Metastases

International Journal of Radiation Oncology Biology Physics, 2009
Michael Milano, Yuhchyau Chen, Alan W Katz   +2 more
exaly  

Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival

Annals of Oncology, 2014
Mark De Ridder, Thierry Gevaert, B Engels   +2 more
exaly